GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study

Keay, 1997, Assisted conception following poor ovarian response to gonadotrophin stimulation, Br J Obstet Gynaecol, 104, 521, 10.1111/j.1471-0528.1997.tb11525.x Tarlatzis, 2003, Clinical management of low ovarian response to stimulation for IVF: a systematic review, Hum Reprod Update, 9, 61, 10.1093/humupd/dmg007 Dor, 1992, The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment, J Assist Reprod Genet, 9, 228, 10.1007/BF01203818 Ulug, 2003, Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles, Reprod Biomed Online, 6, 439, 10.1016/S1472-6483(10)62164-5 Pandian, 2010, Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF), Cochrane Database Syst Rev, CD004379 Goswami, 2004, A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report, Hum Reprod, 19, 2031, 10.1093/humrep/deh359 Yarali, 2009, Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol, Fertil Steril, 92, 231, 10.1016/j.fertnstert.2008.04.057 Mitwally, 2005, The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment, Reprod Biol Endocrinol, 3, 54, 10.1186/1477-7827-3-54 Klein, 1996, Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women, J Clin Endocrinol Metab, 81, 1038 Fanchin, 2003, Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status, Fertil Steril, 79, 585, 10.1016/S0015-0282(02)04757-X Fanchin, 2003, Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists, Hum Reprod, 18, 2698, 10.1093/humrep/deg516 Bakas, 2014, Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old, Gynecol Endocrinol, 30, 825, 10.3109/09513590.2014.932343 Elassar, 2011, Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders, Fertil Steril, 95, 324, 10.1016/j.fertnstert.2010.07.1058 Fanchin, 2004, Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation, Fertil Steril, 81, 1554, 10.1016/j.fertnstert.2003.11.037 Humaidan, 2005, Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol, Reprod Biomed Online, 11, 679, 10.1016/S1472-6483(10)61685-9 Fridén, 2005, Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization, Acta Obstet Gynecol Scand, 84, 812, 10.1111/j.0001-6349.2005.00730.x Nilsson, 2010, Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter ‘extended pilot study’, Acta Obstet Gynecol Scand, 89, 828, 10.3109/00016341003721029 Fanchin, 2005, Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation, Reprod Biomed Online, 10, 721, 10.1016/S1472-6483(10)61115-7 Sunkara, 2011, Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles, Hum Reprod, 26, 1768, 10.1093/humrep/der106 Hardarson, 2001, Human embryos with unevenly sized blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and multinucleation, Hum Reprod, 16, 313, 10.1093/humrep/16.2.313 Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting, Hum Reprod, 26, 1270, 10.1093/humrep/der037 Ferraretti, 2011, ESHRE working group on poor ovarian response definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum Reprod, 26, 1616, 10.1093/humrep/der092 Devreker, 1999, Selection of good embryos for transfer depends on embryo cohort size: implications for the ‘mild ovarian stimulation’ debate, Hum Reprod, 14, 3002, 10.1093/humrep/14.12.3002 Samara, 2015, What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?, Gynecol Endocrinol, 31, 877, 10.3109/09513590.2015.1081680 Cakmak, 2014, A novel delayed start protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders, Fertil Steril, 101, 1308, 10.1016/j.fertnstert.2014.01.050 Younis, 2010, Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles, Fertil Steril, 94, 1350, 10.1016/j.fertnstert.2009.08.033